c.i. 42510 has been researched along with Cranial Nerve II Injuries in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartlett, CA; Fitzgerald, M; Gavriel, N; Gopalasingam, G; Majimbi, M; McGonigle, T; Rodger, J; Toomey, LM | 1 |
| Beker, M; Beker, MC; Caglayan, AB; Caglayan, B; Kelestemur, T; Kilic, E; Kilic, U; Ozturk, G; Sahin, F; Sertel, E; Yalcin, E | 1 |
| Bartlett, CA; Fitzgerald, M; Gopalasingam, G; Majimbi, M; Rodger, J; Toomey, LM | 1 |
| Ohlsson, M; Ridderström, M | 1 |
4 other study(ies) available for c.i. 42510 and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Comparing modes of delivery of a combination of ion channel inhibitors for limiting secondary degeneration following partial optic nerve transection.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Drug Therapy, Combination; Female; Imidazoles; Myelin Sheath; Nerve Degeneration; Optic Nerve; Optic Nerve Injuries; Piperazines; Quinoxalines; Rats; Receptors, AMPA; Receptors, Purinergic P2X7; Rosaniline Dyes | 2019 |
Evidence that activation of P2X7R does not exacerbate neuronal death after optic nerve transection and focal cerebral ischemia in mice.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Brain; Brain Edema; Brain Ischemia; Calcium-Binding Proteins; Cells, Cultured; Cerebral Cortex; Cytokines; Disease Models, Animal; DNA Fragmentation; Infusions, Intraventricular; Male; Mice; Mice, Inbred C57BL; Microfilament Proteins; Neurons; Optic Nerve Injuries; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Rosaniline Dyes | 2017 |
Comparison of ion channel inhibitor combinations for limiting secondary degeneration following partial optic nerve transection.
Topics: Animals; Calcium Channel Blockers; Calcium-Binding Proteins; Cell Adhesion Molecules, Neuronal; Disease Models, Animal; Drug Delivery Systems; Drug Therapy, Combination; Ectodysplasins; Female; Imidazoles; Ion Channels; Macrophages; Microfilament Proteins; Microglia; Nerve Degeneration; Nystagmus, Optokinetic; Oligodendrocyte Transcription Factor 2; Optic Nerve Injuries; Piperazines; Quinoxalines; Rats; Receptor, Platelet-Derived Growth Factor alpha; Rosaniline Dyes; Tubulin | 2019 |
Brilliant blue G treatment facilitates regeneration after optic nerve injury in the adult rat.
Topics: Animals; Axons; Cicatrix; Disease Models, Animal; Immunohistochemistry; Intermediate Filaments; Macrophages; Nerve Regeneration; Neuroglia; Neuroprotective Agents; Optic Nerve Injuries; Random Allocation; Rats, Sprague-Dawley; Rosaniline Dyes | 2014 |